L Rydén, A Hjalmarson, H Wasir, L Werkö. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Acute DiseaseAdultAgedAjmaline/therapeutic useAnti-Arrhythmia Agents/administration & dosageAnti-Arrhythmia Agents/adverse effectsAnti-Arrhythmia Agents/therapeutic useArrhythmias, Cardiac/complicationsArrhythmias, Cardiac/drug therapyBlood Pressure/drug effectsCarbamates/administration & dosageCarbamates/adverse effectsCarbamates/therapeutic useCoronary Disease/complicationsDrug ResistanceElectrocardiographyFemaleHeart Rate/drug effectsHeart Ventricles/physiopathologyHumansHypertension/chemically inducedInfusions, ParenteralLidocaine/therapeutic useMaleMiddle AgedMyocardial Infarction/complicationsPhenytoin/therapeutic useProcainamide/therapeutic useQuaternary Ammonium Compounds/administration & dosageQuaternary Ammonium Compounds/adverse effectsQuaternary Ammonium Compounds/therapeutic useQuinidine/therapeutic useTachycardia/chemically induced
Substances: See more » Anti-Arrhythmia AgentsCarbamatesQuaternary Ammonium CompoundsAjmalinePhenytoinLidocaineQuinidineProcainamide
Year: 1974 PMID: 4413111 PMCID: PMC458899 DOI: 10.1136/hrt.36.8.811
Source DB: PubMed Journal: Br Heart J ISSN: 0007-0769